Doselane

Guides

GLP-1 dose schedules: how Ozempic, Wegovy, Mounjaro and Zepbound step up

A doctor in a white coat talking with a patient across a desk

Photo: Vitaly Gariev / Unsplash

Every weekly GLP-1 starts at a low dose and goes up in steps of at least 4 weeks. The labels say why: the escalation is there to reduce the risk of stomach and gut side effects. Here are the schedules as the US labels print them, and what they leave to your prescriber.

Why the dose goes up in steps

Each label tells prescribers to follow the dose escalation "to reduce the risk of gastrointestinal adverse reactions": nausea, vomiting, diarrhea and the like. The same labels report that most of those reactions happened during the escalation, and for Mounjaro and Zepbound that they decreased over time. More on that in side effects after a GLP-1 shot.

All four at a glance

MedicineStartStepsHighest dose in the label
Wegovy injection0.25 mg, weeks 1–40.5 mg weeks 5–8, 1 mg weeks 9–12, 1.7 mg weeks 13–16, then maintenance7.2 mg (adults, weight reduction, see below)
Ozempic0.25 mg for 4 weeks0.5 mg; then 1 mg and 2 mg, each after at least 4 weeks, if needed for blood sugar control2 mg
Zepbound2.5 mg for 4 weeks5 mg; then up in 2.5 mg steps, each after at least 4 weeks15 mg
Mounjaro2.5 mgup in 2.5 mg steps, each after at least 4 weeks, if needed for blood sugar control15 mg (adults)

All once weekly, from each medicine's US prescribing information (section 2).

Wegovy

Wegovy is the only one of the four with a fixed week-by-week table in its label:

Wegovy escalation: 0.25 mg weeks 1–4, 0.5 mg weeks 5–8, 1 mg weeks 9–12, 1.7 mg weeks 13–16, then 2.4 mg or 1.7 mgWegovy injection: the label's escalationOnce-weekly dose (mg) by week of treatment0.511.522.50.25 mg0.5 mg1 mg1.7 mg2.4 mgwk 1wk 5wk 9wk 13wk 17Weeks 1–16: escalation, 4 weeks per stepWeek 17 on: maintenance, 2.4 mg (recommended) or 1.7 mg
From the Wegovy label (weight reduction in adults). The label lets prescribers delay a step by 4 weeks if a dose isn't tolerated, and allows 7.2 mg for some adults after at least 4 weeks on 2.4 mg.

The daily Wegovy tablets have their own schedule: 1.5 mg on days 1–30, 4 mg on days 31–60, 9 mg on days 61–90, and 25 mg from day 91.

Ozempic

Ozempic is a type 2 diabetes medicine, and its steps after the start depend on blood sugar control:

Each step lasts at least 4 weeks: a dated note of every dose change makes the weeks easy to compare later.
Each step lasts at least 4 weeks: a dated note of every dose change makes the weeks easy to compare later. Photo: Estée Janssens / Unsplash

Zepbound and Mounjaro

Both contain tirzepatide and move in 2.5 mg steps.

Zepbound: 2.5 mg for 4 weeks, then 5 mg, then up in 2.5 mg steps after at least 4 weeks each, to a maximum of 15 mgZepbound: the shortest steps the label allowsOnce-weekly dose (mg); each step lasts at least 4 weeks510152.557.51012.515wk 1+wk 5+wk 9+wk 13+wk 17+wk 21+2.5 mg: starting dose only, for 4 weeks5, 10 or 15 mg: maintenance doses7.5 and 12.5 mg: steps in between
The fastest path the Zepbound label allows, not a plan: many people stay on a dose for longer or stay on a lower maintenance dose. Your prescriber decides.

"At least 4 weeks" is a minimum

Outside Wegovy's fixed table, the labels say at least 4 weeks per step, and they leave the decision to step up, stay, or go back to your prescriber: based on how you're doing and how you tolerate the dose. A schedule that looks slower than the chart is not a sign that something is wrong.

Don't change your dose on your own. Use the dose your prescriber gave you, and ask them or your pharmacist when you're unsure.

After a step up

Because most stomach and gut side effects were reported during the escalation, the weeks right after a step up are the ones worth watching. A useful record is simple: the date of each dose change, and how you felt on each day of the weeks before and after it. Then you can see whether a new dose changed anything, and for how long, and tell your prescriber in facts rather than impressions.

The step-up comparison in Doselane, shown with example data: the weeks before and after a higher dose, side by side.
The step-up comparison in Doselane, shown with example data: the weeks before and after a higher dose, side by side.

This page is general information from the sources below, not medical advice. Your dose and when it changes are decided by your prescriber; follow them and the leaflet that comes with your medicine.

Sources
  1. Wegovy (semaglutide) injection and tablets: US Prescribing Information, Novo Nordisk, revised 06/2026 (sections 2.2 and 2.3, Tables 1 and 2), checked 20 November 2026.
  2. Ozempic (semaglutide) injection: US Prescribing Information, Novo Nordisk, revised 05/2026 (section 2.2), checked 20 November 2026.
  3. Zepbound (tirzepatide) injection: US Prescribing Information, Eli Lilly, revised 11/2026 (sections 2.1 and 2.2), checked 20 November 2026.
  4. Mounjaro (tirzepatide) injection: US Prescribing Information, Eli Lilly, revised 11/2026 (section 2.1), checked 20 November 2026.